67
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Faslpr/J mice

, , , , , , , & show all
Pages 2535-2546 | Published online: 09 Aug 2016

References

  • GuZAkiyamaKMaXTransplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr miceLupus201019131502151420647254
  • Ramsey-GoldmanRDunnJEHuangCFFrequency of fractures in women with systemic lupus erythematosus: comparison with United States population dataArthritis Rheum199942588289010323443
  • BultinkIEOsteoporosis and fractures in systemic lupus erythematosusArthritis Care Res (Hoboken)20126412822213721
  • WeinsteinRSClinical practice. Glucocorticoid-induced bone diseaseN Engl J Med20113651627021732837
  • AdamsJDWangRYangJLienEJPreclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditionsChin Med20061317302964
  • LiYGSongLLiuMHuZBWangZTAdvancement in analysis of Salviae miltiorrhizae Radix et Rhizoma (Danshen)J Chromatogr A20091216111941195319159889
  • CuiLLiTLiuYSalvianolic acid B prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesisPloS One201274e3464722493705
  • CuiLWuTLiuYYDengYFAiCMChenHQTanshinone prevents cancellous bone loss induced by ovariectomy in ratsActa Pharmacol Sin200425567868415132837
  • YangYSuYWangDTanshinol attenuates the deleterious effects of oxidative stress on osteoblastic differentiation via Wnt/FoxO3a signalingOxid Med Cell Longev2013201335189524489983
  • PerryDSangAYinYZhengYYMorelLMurine models of systemic lupus erythematosusJ Biomed Biotechnol2011201127169421403825
  • LiuYCuiYChenYGaoXSuYCuiLEffects of dexamethasone, celecoxib, and methotrexate on the histology and metabolism of bone tissue in healthy Sprague Dawley ratsClin Interv Aging2015101245125326345380
  • DempsterDWCompstonJEDreznerMKStandardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature CommitteeJ Bone Miner Res201328121723197339
  • LinSHuangJZhengLGlucocorticoid-induced osteoporosis in growing ratsCalcif Tissue Int201495436237325086673
  • BynoteKKHackenbergJMKorachKSLubahnDBLanePHGouldKAEstrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB x NZW)F1 miceGenes Immun20089213715218200028
  • PineauCAUrowitzMBFortinPJIbanezDGladmanDDOsteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone densityLupus200413643644115303570
  • SchapiraDKabalaARazBIsraeliEOsteoporosis in murine systemic lupus erythematosus – a laboratory modelLupus200110643143811434579
  • Ekblom-KullbergSKautiainenHAlhaPLeirisalo-RepoMJulkunenHFrequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosusScand J Rheumatol201342539039323721483
  • TangXLQinLKwokAWAlterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCTOsteoporos Int20132461817182623104200
  • EngdahlCLindholmCStubeliusAOhlssonCCarlstenHLagerquistMKPeriarticular bone loss in antigen-induced arthritisArthritis Rheum201365112857286523918694
  • ManolagasSCWeinsteinRSNew developments in the pathogenesis and treatment of steroid-induced osteoporosisJ Bone Miner Res19991471061106610404005
  • HenneickeHGaspariniSJBrennan-SperanzaTCZhouHSeibelMJGlucocorticoids and bone: local effects and systemic implicationsTrends Endocrinol Metab201425419721124418120
  • PatschanDLoddenkemperKButtgereitFMolecular mechanisms of glucocorticoid-induced osteoporosisBone200129649850511728918
  • LiuYChenYZhaoHZhongLWuLCuiLEffects of different doses of dexamethasone on bone qualities in ratsSheng Wu Yi Xue Gong Cheng Xue Za Zhi2011284737743747 Chinese21936372
  • AlmeidaMHanLAmbroginiEWeinsteinRSManolagasSCGlucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblastsJ Biol Chem201128652443264433522030390
  • SongLQiuFFanYGlucocorticoid regulates interleukin-37 in systemic lupus erythematosusJ Clin Immunol201333111111722961070
  • IgarashiYLeeMYMatsuzakiSAcid phosphatases as markers of bone metabolismJ Chromatogr B Analyt Technol Biomed Life Sci20027811–2345358
  • WhitakerMGuoJKehoeTBensonGBisphosphonates for osteoporosis – where do we go from here?N Engl J Med2012366222048205122571168
  • GattiDViapianaOAdamiSIdolazziLFracassiERossiniMBisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostinBone201250373974222178539
  • KraenzlinMEMeierCParathyroid hormone analogues in the treatment of osteoporosisNat Rev Endocrinol201171164765621750510
  • CuiLLiuYYWuTAiCMChenHQOsteogenic effects of D+beta-3,4-dihydroxyphenyl lactic acid (salvianic acid A, SAA) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated ratsActa Pharmacol Sin200930332133219262556
  • DayTFGuoXGarrett-BealLYangYWnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesisDev Cell20058573975015866164
  • OhnakaKTaniguchiHKawateHNawataHTakayanagiRGlucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosisBiochem Biophys Res Commun2004318125926415110782
  • ChenDZhaoMMundyGRBone morphogenetic proteinsGrowth Factors200422423324115621726
  • HamidoucheZHayEVaudinPFHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expressionFASEB J200822113813382218653765
  • NakashimaKZhouXKunkelGThe novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formationCell20021081172911792318
  • KhoslaSMinireview: the OPG/RANKL/RANK systemEndocrinology2001142125050505511713196
  • Kwan TatSPadrinesMTheoleyreSHeymannDFortunYIL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiologyCytokine Growth Factor Rev2004151496014746813
  • IshimiYMiyauraCJinCHIL-6 is produced by osteoblasts and induces bone resorptionJ Immunol199014510329733032121824
  • WauquierFLeotoingLCoxamVGuicheuxJWittrantYOxidative stress in bone remodelling and diseaseTrends Mol Med2009151046847719811952
  • FeiAHCaoQChenSYSalvianolate inhibits reactive oxygen species production in H(2)O(2)-treated mouse cardiomyocytes in vitro via the TGFbeta pathwayActa Pharmacol Sin201334449650023524570
  • ShockleyKRRosenCJChurchillGALecka-CzernikBPPAR-gamma2 regulates a molecular signature of marrow mesenchymal stem cellsPPAR Res200720078121918288266
  • LiebschnerMAKellerTSHydraulic strengthening affects the stiffness and strength of cortical boneAnn Biomed Eng2005331263815709703
  • XuMWangYPLuoWBXuanLJSalvianolate inhibits proliferation and endothelin release in cultured rat mesangial cellsActa Pharmacol Sin200122762963311749828
  • FuPHuangXQYuanAHYuGMeiXBCuiRLEffects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trialZhong Xi Yi Jie He Xue Bao2012106641646 Chinese22704412